On World Cancer Day, we got in touch with an Orthopaedic Oncologist who shares the importance of early detection and expert ...

In a mouse model of fibrodysplasia ossificans progressiva (FOP)—a genetic condition causing abnormal bone growth in soft tissues—DDR2 deficiency markedly reduced heterotopic ossification.

the reduced menace response indicates that either the II cranial nerve involved in the visual pathway or the VII cranial nerve for the facial response was affected by the abnormal bone growth.

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

Heterotopic ossification (HO) is the de novo formation of bone at extraskeletal sites. This abnormal bone growth can be found clinically as a result of trauma or as a complication after surgeries such ...

In a mouse model of fibrodysplasia ossificans progressiva (FOP)-a genetic condition causing abnormal bone growth in soft tissues-DDR2 deficiency markedly reduced heterotopic ossification.

"For the first time, doctors have an approved medicine available to them, shown to reduce the formation of new, abnormal bone growth, known as heterotopic ossification (HO), which causes ...

graft recipients frequently continue to experience accelerated bone loss. Fleseriu and Licata had observed that some renal transplant recipients had abnormal 1,25-dihydroxyvitamin D 3 levels ...